Results from the largest and longest study of its kind have found that the drug metformin can help manage weight gain in ...

Ms. Pai Panandiker is a seasoned commercial and operating leader with more than 20 years of global biopharmaceutical experience, including extensive leadership in neuroscience commercialization and in ...

Data from the SERENITY At-Home Phase 3 trial were presented on November 7 at the 2025 Neuroscience Education Institute Fall Congress by Dr. Leslie Citrome.

This article proposes a multiphase bipolar-output hybrid (BOH) converter designed to achieve a high conversion ratio, minimal output ripple, and enhanced efficiency. By incorporating a dynamic charge ...

A new study examining real-world hospital data reveals early indicators of who is most likely to benefit from Cobenfy, the ...

The new approval is the first for the drug under JNJ leadership. ・The drug is also approved for the treatment of bipolar I and II depression as well as schizophrenia in adults. ・JNJ recently submitted ...

Lumateperone is approved as an adjunctive treatment for MDD, expanding its indications beyond schizophrenia and bipolar ...

The J&J antipsychotic drug Caplyta won FDA approval for depression, a broader indication that could help the medicine become ...